Status:
COMPLETED
Improve Timely Referral Flow and Compliance of Diabetic Retinopathy Patients
Lead Sponsor:
Seva Foundation
Collaborating Sponsors:
Lumbini Eye Institute and Research Centre
Indian Institute of Public Health, India
Conditions:
Diabetes
Diabetic Retinopathy
Eligibility:
All Genders
16-100 years
Phase:
NA
Brief Summary
An effective referral system helps to ensure a close relationship between all levels of the health system and ensures clients receive optimum care at the appropriate level and at affordable cost, and ...
Detailed Description
Background: Changes in lifestyle and a growing number of aging populations have increased the prevalence of diabetes worldwide. Diabetes imposes a heavy disease burden in both developed and developing...
Eligibility Criteria
Inclusion
- All Diabetic Retinopathy patients attending the peripheral eye centers linked with LEIRC.
Exclusion
- All referred Diabetic patients who not is willing to be part of the study.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04834648
Start Date
March 15 2021
End Date
December 30 2021
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lumbini Eye Institute and Research Center
Butwāl, Nepal